Drug common name | Dovitinib |
INN | dovitinib |
Description | 4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone is a N-arylpiperazine. |
Classification | Small molecule |
Drug class | tyrosine kinase inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1 |
PDB | — |
CAS-ID | 1027263-12-2 |
RxCUI | — |
ChEMBL ID | CHEMBL522892 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | I35H55G906 (ChemIDplus, GSRS) |